ClinicalTrials.Veeva

Menu

Preventing Childhood Antibiotic-associated Diarrhea by Prebiotics (WGAAD)

S

Soroka University Medical Center

Status and phase

Completed
Phase 3

Conditions

Antibiotic-Associated Diarrhea

Treatments

Dietary Supplement: Inulin and fructo-oligosaccharides.
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00826137
Sor472908ctil

Details and patient eligibility

About

Prospective randomized double-blind study on the effect of prebiotics (inulin and fructo-oligosaccharides) in the prevention of antibiotic-associated diarrhea in children.

Full description

Group will get either the product or placebo blindly throughout antibiotic treatment with additional 14 days.

Enrollment

200 patients

Sex

All

Ages

6 months to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy children with acute infection.

Exclusion criteria

  • Hypersensitivity to antibiotics, chronic illness.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

200 participants in 2 patient groups, including a placebo group

A
Experimental group
Description:
Treated with prebiotics.
Treatment:
Dietary Supplement: Inulin and fructo-oligosaccharides.
B
Placebo Comparator group
Description:
Placebo treated.
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems